GGrantIndex
← Search

S4 TO 108 NCATS GENE THERAPY VECTOR

$2,338,050N02FY2023ODNIH

Medical Science & Computing, Llc, Rockville MD

Investigators

Abstract

Produce and deliver a research grade gene therapy vector for a potential lead candidate for hereditary methylmalonic acidemias using AAV9 platform-based gene therapy vector platform.

View original record on NIH RePORTER →